- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02961192
Social Incentives to Improve Diabetes (iDiabetes)
Using Social Incentives and Patient-Generated Health Data to Change Health Behaviors and Improve Glycemic Control Among Type 2 Diabetics
Study Overview
Status
Conditions
Detailed Description
This is a four-arm, one-year randomized, controlled trial. The study will be conducted using Way to Health, an automated information technology platform at the University of Pennsylvania that integrates wireless devices, conducts clinical trial randomization and enrollment processes, delivers messaging (text or email) delivers self-administered surveys, automates payment transfers, and securely captures data for research purposes.
The study team will identify potential participants from the electronic health record at the University of Pennsylvania Health System. Interested participants will be instructed to visit the study website to create an account, review and complete informed consent, and complete an eligibility survey. Eligible participants will be instructed to obtain a hemoglobin A1c and LDL-C laboratory test. If the hemoglobin A1c is 8.0 or greater and the participant is still interested in continuing the enrollment process, a wearable activity tracking device will be mailed to them. After that, the participant will be scheduled for an in-person visit with the study team to complete the enrollment process.
Participants will be randomly assigned in blocks of four groups to one of the four study arms stratified based on whether the group of individuals already knew each other or not. Groups will have three individuals unless the individuals were already socially connected prior to the study, in which case they will be allowed to be randomized as a group of two or three. Participants randomized to the control arm will receive no other interventions.
Each participant in the intervention arms will be asked to choose their goals for the study as follows: 1) Choose a weight loss goal that is 6%, 7%, or 8% of their baseline weight rounded up to the next pound; 2) Choose a daily step count goal that is 33%, 40%, or 50% greater than their baseline rounded up to the nearest hundred, or choose their own step goal as long as it is at least 1500 steps above their baseline; 3) Choose a HbA1c reduction goal of 1.5%, 2%, or 2.5%.
Participants in arms 2-4 will be entered into an intervention approach that has points and levels designed to incorporate insights from behavioral economics. On a daily basis, they will be asked to weigh-in. They will have a weekly weight target and mean step goal. Weekly feedback will differ among the three arms to induce the different social incentives.
The primary outcome variables are change in mean daily steps, weight in pounds, and hemoglobin A1c from baseline to end of the one-year study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years to 70 years
- Ability to read and provide informed consent to participate in the study
- Diagnosis of type 2 diabetes with a hemoglobin A1c of 8.0 or greater
- Self-reported body mass index (BMI) of 25 or greater.
- Smartphone or tablet compatible with the application for the wearable activity tracking device and wireless weight scale.
Exclusion Criteria:
- Conditions that would make participation infeasible such as inability to provide informed consent, illiteracy or inability to speak, read, and write English
- Conditions that would make participation unsafe such as pregnancy, previous diagnosis of an eating disorder, or history of unsafe weight loss practices
- Already enrolled in another study targeting physical activity, weight loss, or glycemic control
- Any other medical conditions or reasons he or she is unable to participate in the study for one year.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Participants will receive a wireless weight scale and a wearable activity tracker to monitor their weight and step counts.
|
|
|
Experimental: Supportive
Participants will receive a wireless weight scale and a wearable activity tracker to monitor their weight and step counts.
Additionally, participants will play a game designed with insights from behavioral economics.
The game will involve points and levels.
In addition to playing the game, participants will identify a family member or friend to receive updates and support them in their progress.
|
A family member or friend will be used as a support person in this study, to receive updates and support the participant in their progress.
|
|
Experimental: Competitive
Participants will receive a wireless weight scale and a wearable activity tracker to monitor their weight and step counts.
Additionally, participants will play a game designed with insights from behavioral economics.
The game will involve points and levels.
In this arm, participants will be placed into competitive groups with one or two other participants to play the game.
|
Participants in this intervention will be competing against each other in the game.
|
|
Experimental: Collaborative
Participants will receive a wireless weight scale and a wearable activity tracker to monitor their weight and step counts.
Additionally, participants will play a game designed with insights from behavioral economics.
The game will involve points and levels.
In this arm, participants will be placed into collaborative groups with one or two other participants to play the game.
|
Participants in this intervention will be working with each other in the game.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in hemoglobin A1c
Time Frame: 12 months
|
Change in hemoglobin A1c from baseline to the end of the one-year study.
|
12 months
|
|
Change in weight in pounds
Time Frame: 12 months
|
Change in weight in pounds from baseline to the end of the one-year study.
|
12 months
|
|
Change in mean daily steps
Time Frame: 12 months
|
Change in baseline step count compared to the entire one-year study period.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mean daily steps
Time Frame: 6 months
|
Change in baseline step count compared to the first 6 months of the study period
|
6 months
|
|
Change in weight in pounds from baseline to the study midpoint
Time Frame: 6 months
|
Change in weight from baseline to the six-month midpoint of the study
|
6 months
|
|
Change in hemoglobin A1c from baseline to the study midpoint
Time Frame: 6 months
|
Change in hemoglobin A1c to the six-month midpoint of the study
|
6 months
|
|
Change in LDL-C levels
Time Frame: 6 months
|
Change in LDL-C from baseline to the six-month midpoint of the study
|
6 months
|
|
Change in LDL-C levels
Time Frame: 12 months
|
Change in LDL-C from baseline to the end of the one-year study.
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mitesh Patel, MD, MBA, University of Pennsylvania
Publications and helpful links
General Publications
- Patel MS, Small DS, Harrison JD, Hilbert V, Fortunato MP, Oon AL, Rareshide CAL, Volpp KG. Effect of Behaviorally Designed Gamification With Social Incentives on Lifestyle Modification Among Adults With Uncontrolled Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2021 May 3;4(5):e2110255. doi: 10.1001/jamanetworkopen.2021.10255.
- Fortunato M, Harrison J, Oon AL, Small D, Hilbert V, Rareshide C, Patel M. Remotely Monitored Gamification and Social Incentives to Improve Glycemic Control Among Adults With Uncontrolled Type 2 Diabetes (iDiabetes): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2019 Nov 20;8(11):e14180. doi: 10.2196/14180.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 825372
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Supportive social incentive
-
University of PennsylvaniaDeloitteCompletedObesityUnited States
-
Carnegie Mellon UniversityUniversity of VirginiaCompletedSocial Isolation | Activity, MotorUnited States
-
University of PennsylvaniaCompletedPneumonia | Diabetes | Chronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States
-
University of PennsylvaniaCompletedStroke | Ischemic Attack, TransientUnited States
-
University of ManchesterEconomic and Social Research Council, United KingdomCompletedWillingness to ParticipateUnited Kingdom
-
VA Office of Research and DevelopmentCompletedPhysical ActivityUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Boston University; University of PennsylvaniaCompletedPhysical Activity
-
University of PennsylvaniaCompletedBladder CancerUnited States
-
George Washington UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Gilead SciencesCompletedPre-Exposure ProphylaxisUnited States
-
University of PennsylvaniaCompleted